Schnitzler's syndrome: Successful treatment with anakinra
Authors:
- 31 July 2007
- journal article
- case report
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 48 (3) , 178-181
Abstract
SUMMARY: A 44‐year‐old man presented with a 2‐year history of an intermittent urticarial rash, malaise, weight loss, night sweats, headaches and bone pains. Initial investigations indicated an elevated erythrocyte sedimentation rate, white cell count and a monoclonal immunoglobulin‐M paraprotein. Histological examination revealed a perivascular mixed inflammatory infiltrate with leukocytoclasis, nuclear dust without fibrinoid necrosis and extravasated red blood cells. A diagnosis of Schnitzler's syndrome was made. Over an 8‐year period, the patient was treated with continuous oral prednisone (minimum dose 20 mg/day) combined with multiple systemic agents. He was commenced on anakinra, a recombinant form of human interleukin‐1 receptor antagonist, at a dose of 100 mg injected subcutaneously daily. On review 1 week later, the patient's systemic symptoms had resolved, and his previously elevated white cell count and inflammatory markers had normalized. The use of anakinra in our patient resulted in resolution of symptoms and has enabled cessation of oral prednisone. Our patient remains symptom free on anakinra after 14 months of follow up.Keywords
This publication has 8 references indexed in Scilit:
- Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome‐associated febrile crisisJournal of Inherited Metabolic Disease, 2006
- Beneficial response to anakinra and thalidomide in Schnitzler's syndromeAnnals of the Rheumatic Diseases, 2006
- Successful treatment of refractory Schnitzler syndrome with anakinra: Comment on the article by Hawkins et alArthritis & Rheumatism, 2005
- Beneficial response to interleukin 1 receptor antagonist in trapsThe American Journal of Medicine, 2004
- Spectrum of clinical features in Muckle‐Wells syndrome and response to anakinraArthritis & Rheumatism, 2004
- Report of a Case of Schnitzler’s Syndrome Treated Successfully with Interferon Alpha 2bDermatology, 2002
- Schnitzler’s syndrome: Report of a case with progression to Waldenström’s macroglobulinaemiaAustralasian Journal of Dermatology, 1999
- Anti-interleukin-1α autoantibodies in humans: Characterization, isotype distribution, and receptor-binding inhibition—Higher frequency in Schnitzler's syndrome (urticaria and macroglobulinemia)Journal of Allergy and Clinical Immunology, 1991